Screener
Agios Pharmaceuticals AGIO Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 51,547 | 45,869 | 99,851 | 87,396 |
| Total operating expenses | 155,297 | 139,511 | 286,068 | 254,866 |
| Loss from operations | (110,552) | (127,056) | (220,577) | (233,685) |
| Interest income, net | 9,730 | 14,513 | 20,525 | 30,600 |
| Other income, net | 119 | 523 | 238 | 1,776 |
| Net loss | $(100,703) | $(112,020) | $(199,814) | $(201,309) |
| Net loss per share - basic and diluted | $(1.69) | $(1.93) | $(3.38) | $(3.49) |
| Weighted-average number of common shares used in computing net loss per share – basic and diluted | 59,488,871 | 57,932,576 | 59,137,508 | 57,697,193 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's interest expense?
- Agios Pharmaceuticals (AGIO) reported interest expense of $9.73M in Q2 2026.
- How has Agios Pharmaceuticals's interest expense changed year-over-year?
- Agios Pharmaceuticals's interest expense decreased by 33.0% year-over-year, from $14.51M to $9.73M.
- What is the long-term trend for Agios Pharmaceuticals's interest expense?
- Over 3 years (2021 to 2025), Agios Pharmaceuticals's interest expense has grown at a 307.0% compound annual growth rate (CAGR), from $836K to $56.38M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Agios Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude